adalimumab
abbvie
[' ada ', 'ada ']
barroso-garc a et al. ada vs ifx vs tcz in severe ocular behcets with refractory cystoid macular edema. remission 76% (ada), 60% (ifx), 67% (tcz). #acr22 abstr#1564 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC